Britain's drugs cost-effectiveness watchdog NICE said on Thursday it will recommend Eli Lilly's obesity drug Mounjaro be made ...

Speaking at The New York Times’s DealBook Summit, Eli Lilly’s chief executive and an obesity medicine specialist discussed ...

Leptin by itself doesn't hold promise for weight loss — but a new mouse study suggests it could work in combination with ...

Following its endorsement of Eli Lilly’s obesity medicine tirzepatide, England’s National Institute for Health and Care ...

The U.K. will soon offer Eli Lilly's Mounjaro for people with obesity — but only to a small share of those medically eligible ...

Obesity and visceral fat are associated with measures of amyloid burden in the brain among cognitively normal midlife ...

Lisa Schaffer, with Obesity Canada, joined CTV Morning Live’s Kent Morrison to call for systemic changes on how people view ...

Mounjaro will be rolled out gradually as officials said a "difficult decision" had to be made in order to "protect other ...

Those treated with tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist, lost on ...

A virtual simulation of interactions between complex biological membranes and alternative bisphenols indicates that BPF and ...

Results from the head-to-head study showed treatment with Zepbound resulted in 47% greater relative weight loss than Wegovy, ...

Brands that make unhealthy foods will be able to get round the government's junk food advertising ban if their adverts don't ...